The chart was, in truth, a parody of analysis. Even the presenter acknowledged it was unlikely. But that was never the point. The intent was to frame stakeholder calls for greater investment in innovative health technologies as a direct threat to national solvency. The underlying message was clear. The demand is against the national interest.
The continued 'false framing' aims to make us feel guilty for wanting more on health
October 31, 2025 Latest NewsBioPharmaComment 
		Latest Video
New Stories
- 
					
						The 'Dispatched' Week in Review Podcast - 31 OctoberOctober 31, 2025 - - Podcast
- 
					
						Aroa Biosurgery appoints Paul Shearer to Board as John Pinion retiresOctober 31, 2025 - - Australian Biotech
- 
					
						Immuron provides update on U.S. clinical trials for Travelan and IMM-529October 31, 2025 - - Australian Biotech
- 
					
						Firebrick Pharma launches new Nasodine Throat Spray for international marketsOctober 31, 2025 - - Australian Biotech
- 
					
						Amplia Therapeutics begins trading on U.S. OTCQB Venture MarketOctober 31, 2025 - - Australian Biotech
- 
					
						DHL Supply Chain opens New Zealand’s most advanced life sciences and healthcare logistics facilityOctober 31, 2025 - - Latest News
- 
					
						The continued 'false framing' aims to make us feel guilty for wanting more on healthOctober 31, 2025 - - Latest News
